AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
MARGIN OF RESECTION IN THE MANAGEMENT OF PRIMARY MELANOMA
Authors: CASCINELLI N
Citation: N. Cascinelli, MARGIN OF RESECTION IN THE MANAGEMENT OF PRIMARY MELANOMA, Seminars in surgical oncology, 14(4), 1998, pp. 272-275
S100 PROTEIN SERUM LEVELS IN CUTANEOUS MALIGNANT-MELANOMA
Authors: SEREGNI E MASSARON S MARTINETTI A ILLENI MT ROVINI D BELLI F AGRESTI R GRECO M CASCINELLI N BOMBARDIERI E
Citation: E. Seregni et al., S100 PROTEIN SERUM LEVELS IN CUTANEOUS MALIGNANT-MELANOMA, Oncology Reports, 5(3), 1998, pp. 601-604
SPECTROPHOTOMETRIC IMAGING OF CUTANEOUS PIGMENTED LESIONS - DISCRIMINANT-ANALYSIS, OPTICAL-PROPERTIES AND HISTOLOGICAL CHARACTERISTICS
Authors: TOMATIS S BARTOLI C BONO A CASCINELLI N CLEMENTE C MARCHESINI R
Citation: S. Tomatis et al., SPECTROPHOTOMETRIC IMAGING OF CUTANEOUS PIGMENTED LESIONS - DISCRIMINANT-ANALYSIS, OPTICAL-PROPERTIES AND HISTOLOGICAL CHARACTERISTICS, Journal of photochemistry and photobiology.B, Biology, 42(1), 1998, pp. 32-39
COMBINED EFFECTS OF INTERFERON-ALPHA-2A AND 13-CIS-RETINOIC ACID ON HUMAN-MELANOMA CELL-GROWTH AND STAT PROTEIN EXPRESSION
Authors: BEARZATTO A ORLANDI L SILVESTRINI R BELLI F CASCINELLI N ZAFFARONI N
Citation: A. Bearzatto et al., COMBINED EFFECTS OF INTERFERON-ALPHA-2A AND 13-CIS-RETINOIC ACID ON HUMAN-MELANOMA CELL-GROWTH AND STAT PROTEIN EXPRESSION, Melanoma research, 8(1), 1998, pp. 31-38
EVALUATION OF CLINICAL EFFICACY AND TOLERABILITY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN ADVANCED MELANOMA PATIENTS
Authors: CASCINELLI N BELLI F MASCHERONI L LENISA L CLEMENTE C
Citation: N. Cascinelli et al., EVALUATION OF CLINICAL EFFICACY AND TOLERABILITY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN ADVANCED MELANOMA PATIENTS, Melanoma research, 8(1), 1998, pp. 83-89
SENTINEL NODE BIOPSY AND SELECTIVE DISSECTION FOR MELANOMA NODAL METASTASES
Authors: BELLI F LENISA L CLEMENTE C TRAGNI G MASCHERONI L GALLINO G CASCINELLI N
Citation: F. Belli et al., SENTINEL NODE BIOPSY AND SELECTIVE DISSECTION FOR MELANOMA NODAL METASTASES, Tumori, 84(1), 1998, pp. 24-28
EVALUATION ON SERUM 2'-5' OLIGOADENYLATE SYNTHETASE (2'-5' OLIGOAS) AND BETA-2-MICROGLOBULIN (B2M) IN PATIENTS WITH NODAL METASTASES FROM CUTANEOUS MALIGNANT-MELANOMA TREATED WITH RIFN-ALPHA-2A
Authors: MARTINETTI A SEREGNI E BELLI F MAZZOCCHI A AGRESTI R CASCINELLI N GRECO M BOMBARDIERI E
Citation: A. Martinetti et al., EVALUATION ON SERUM 2'-5' OLIGOADENYLATE SYNTHETASE (2'-5' OLIGOAS) AND BETA-2-MICROGLOBULIN (B2M) IN PATIENTS WITH NODAL METASTASES FROM CUTANEOUS MALIGNANT-MELANOMA TREATED WITH RIFN-ALPHA-2A, Anticancer research, 18(3B), 1998, pp. 2027-2030
DISSECTION OF REGIONAL LYMPH-NODES IN CUTANEOUS MELANOMA - REPLY
Authors: CASCINELLI N MORABITO A SANTINAMI M MACKIE RM BELLI F
Citation: N. Cascinelli et al., DISSECTION OF REGIONAL LYMPH-NODES IN CUTANEOUS MELANOMA - REPLY, Lancet, 351(9119), 1998, pp. 1885-1885
IMMEDIATE OR DELAYED DISSECTION OF REGIONAL NODES IN PATIENTS WITH MELANOMA OF THE TRUNK - A RANDOMIZED TRIAL
Authors: CASCINELLI N MORABITO A SANTINAMI M MACKIE RM BELLI F
Citation: N. Cascinelli et al., IMMEDIATE OR DELAYED DISSECTION OF REGIONAL NODES IN PATIENTS WITH MELANOMA OF THE TRUNK - A RANDOMIZED TRIAL, Lancet, 351(9105), 1998, pp. 793-796
NEUROTOXICITY OF INTERFERON-ALPHA IN MELANOMA THERAPY - RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
Authors: CARACENI A GANGERI L MARTINI C BELLI F BRUNELLI C BALDINI M MASCHERONI L LENISA L CASCINELLI N
Citation: A. Caraceni et al., NEUROTOXICITY OF INTERFERON-ALPHA IN MELANOMA THERAPY - RESULTS FROM A RANDOMIZED CONTROLLED TRIAL, Cancer, 83(3), 1998, pp. 482-489
LYMPHOID INFILTRATION AS A PROGNOSTIC VARIABLE FOR EARLY-ONSET BREASTCARCINOMAS
Authors: MENARD S TOMASIC G CASALINI P BALSARI A PILOTTI S CASCINELLI N SALVADORI B COLNAGHI MI RILKE F
Citation: S. Menard et al., LYMPHOID INFILTRATION AS A PROGNOSTIC VARIABLE FOR EARLY-ONSET BREASTCARCINOMAS, Clinical cancer research, 3(5), 1997, pp. 817-819
AMBULATORY NARROW EXCISION FOR THIN MELANOMA (LESS-THAN-OR-EQUAL-TO-2MM) - RESULTS OF A PROSPECTIVE-STUDY
Authors: BONO A BARTOLI C CLEMENTE C DELPRATO I BORACCHI P ROSSI N CASCINELLI N
Citation: A. Bono et al., AMBULATORY NARROW EXCISION FOR THIN MELANOMA (LESS-THAN-OR-EQUAL-TO-2MM) - RESULTS OF A PROSPECTIVE-STUDY, European journal of cancer, 33(8), 1997, pp. 1330-1332
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH IL-2 OR IL-4GENE TRANSFERRED, ALLOGENEIC MELANOMA-CELLS
Authors: BELLI F MASCHERONI L GALLINO G LENISA L ARIENTI F PARMIANI G CASCINELLI N
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH IL-2 OR IL-4GENE TRANSFERRED, ALLOGENEIC MELANOMA-CELLS, Cancer gene therapy, 4(5), 1997, pp. 334-334
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY (VOL 44, PG 197, 1997)
Authors: BELLI F ARIENTI F SULESUSO J CLEMENTE C MASCHERONI L CATTELAN A SANTANTONIO C GALLINO GF MELANI C RAO S COLOMBO MP MAIO M CASCINELLI N PARMIANI G
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY (VOL 44, PG 197, 1997), Cancer immunology and immunotherapy, 45(2), 1997, pp. 119-119
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY
Authors: BELLI F ARIENTI F SULESUSO J CLEMENTE C MASCHERONI L CATTELAN A SANANTONIO C GALLINO GF MELANI C RAO S COLOMBO MP MAIO M CASCINELLI N PARMIANI G
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY, Cancer immunology and immunotherapy, 44(4), 1997, pp. 197-203
PHARMACOKINETICS AND EFFECTS ON PLASMA RETINOL CONCENTRATIONS OF 13-CIS-RETINOIC ACID IN MELANOMA PATIENTS
Authors: FORMELLI F CAVADINI E MASCHERONI L BELLI F CASCINELLI N
Citation: F. Formelli et al., PHARMACOKINETICS AND EFFECTS ON PLASMA RETINOL CONCENTRATIONS OF 13-CIS-RETINOIC ACID IN MELANOMA PATIENTS, British Journal of Cancer, 76(12), 1997, pp. 1655-1660
NO ADDITIVE IMPACT ON PATIENT SURVIVAL OF THE DOUBLE ALTERATION OF P53 AND C-ERBB-2 IN BREAST CARCINOMAS
Authors: MENARD S CASALINI P PILOTTI S CASCINELLI N RILKE F COLNAGHI MI
Citation: S. Menard et al., NO ADDITIVE IMPACT ON PATIENT SURVIVAL OF THE DOUBLE ALTERATION OF P53 AND C-ERBB-2 IN BREAST CARCINOMAS, Journal of the National Cancer Institute, 88(14), 1996, pp. 1002-1003
LIMITED ANTITUMOR T-CELL RESPONSE IN MELANOMA PATIENTS VACCINATED WITH INTERLEUKIN-2 GENE-TRANSDUCED ALLOGENEIC MELANOMA-CELLS
Authors: ARIENTI F SULESUSO J BELLI F MASCHERONI L RIVOLTINI L MELANI C MAIO M CASCINELLI N COLOMBO MP PARMIANI G
Citation: F. Arienti et al., LIMITED ANTITUMOR T-CELL RESPONSE IN MELANOMA PATIENTS VACCINATED WITH INTERLEUKIN-2 GENE-TRANSDUCED ALLOGENEIC MELANOMA-CELLS, Human gene therapy, 7(16), 1996, pp. 1955-1963
BIOLOGICAL-ACTIVITY AND CLINICAL EFFICACY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN METASTATIC MELANOMA PATIENTS
Authors: CLEMENTE C BELLI F MASCHERONI L BUFALINO R RAO S BALDINI MT MIHM MC CASCINELLI N
Citation: C. Clemente et al., BIOLOGICAL-ACTIVITY AND CLINICAL EFFICACY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN METASTATIC MELANOMA PATIENTS, Melanoma research, 6(1), 1996, pp. 63-69
THE INVISIBLE COLORS OF MELANOMA - A TELESPECTROPHOTOMETRIC DIAGNOSTIC-APPROACH ON PIGMENTED SKIN-LESIONS
Authors: BONO A TOMATIS S BARTOLI C CASCINELLI N CLEMENTE C CUPETA C MARCHESINI R
Citation: A. Bono et al., THE INVISIBLE COLORS OF MELANOMA - A TELESPECTROPHOTOMETRIC DIAGNOSTIC-APPROACH ON PIGMENTED SKIN-LESIONS, European journal of cancer, 32A(4), 1996, pp. 727-729
THE ROLE OF CLINICAL-TRIALS IN ASSESSING OPTIMAL TREATMENT OF CUTANEOUS MELANOMA NOT EXTENDING BEYOND THE REGIONAL NODES
Authors: CASCINELLI N
Citation: N. Cascinelli, THE ROLE OF CLINICAL-TRIALS IN ASSESSING OPTIMAL TREATMENT OF CUTANEOUS MELANOMA NOT EXTENDING BEYOND THE REGIONAL NODES, European journal of surgical oncology, 22(2), 1996, pp. 123-127
PRELIMINARY EXPERIENCE WITH RHU IL-12 IN THE TREATMENT OF METASTATIC MELANOMA
Authors: DELVECCHIO M MORTARINI R RIMASSA L FOWST C ANICHINI A PARMIANI G CASCINELLI N BAJETTA E
Citation: M. Delvecchio et al., PRELIMINARY EXPERIENCE WITH RHU IL-12 IN THE TREATMENT OF METASTATIC MELANOMA, Journal of clinical oncology, 14(5), 1996, pp. 2011-2011
IN-SITU AND VERY THIN MELANOMAS (LESS-THAN-0.75 MM) ARE SIMILARLY ANDCOMMONLY RECOGNIZABLE
Authors: BONO A BARTOLI C TESSANDRI L DELPRATO I TRAGNI G BUCCI A MOGLIA D CASCINELLI N
Citation: A. Bono et al., IN-SITU AND VERY THIN MELANOMAS (LESS-THAN-0.75 MM) ARE SIMILARLY ANDCOMMONLY RECOGNIZABLE, Tumori, 82(6), 1996, pp. 600-602
SOLITARY MELANOMA METASTASIS OF THE KIDNEY - A CASE-REPORT
Authors: LENISA L TRAGNI G BELLI F GALLINO G MASCHERONI L CASCINELLI N
Citation: L. Lenisa et al., SOLITARY MELANOMA METASTASIS OF THE KIDNEY - A CASE-REPORT, Tumori, 82(6), 1996, pp. 614-615
TUMOR-INFILTRATING LYMPHOCYTES IN LYMPH-NODE MELANOMA METASTASES - A HISTOPATHOLOGIC PROGNOSTIC INDICATOR AND AN EXPRESSION OF LOCAL IMMUNE-RESPONSE
Authors: MIHM MC CLEMENTE CG CASCINELLI N
Citation: Mc. Mihm et al., TUMOR-INFILTRATING LYMPHOCYTES IN LYMPH-NODE MELANOMA METASTASES - A HISTOPATHOLOGIC PROGNOSTIC INDICATOR AND AN EXPRESSION OF LOCAL IMMUNE-RESPONSE, Laboratory investigation, 74(1), 1996, pp. 43-47
Risultati: 1-25 | 26-50 | 51-54